Paper482183
Cimetidine in the prevention of gastric ulcer relapse.
Machell RJ and 4 others. Postgrad Med J, 1979. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cimetidine in the prevention of gastric ulcer relapse. Papers, record 482183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/482183
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Guanidines | Major topic |
| Stomach Ulcer | Major topic |
| Aged | |
| Double-Blind Method | |
| Evaluation Studies as Topic | |
| Humans | |
| Middle Aged | |
| Random Allocation | |
| Recurrence |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 76,166 | Prevention by bedtime cimetidine of duodenal-ulcer relapse. | Lancet | 1978 | https://conductscience.org/library/papers/76166 | PubMed |
| 2 | 73,797 | Cimetidine in duodenal ulcer. Controlled trial. | Lancet | 1976 | https://conductscience.org/library/papers/73797 | PubMed |
| 3 | 73,792 | Cimetidine in the treatment of active duodenal and prepyloric ulcers. | Lancet | 1976 | https://conductscience.org/library/papers/73792 | PubMed |
| 4 | 340,331 | Cimetidine and placebo in the treatment of benign gastric ulcer: a multicenter double blind study. | Gastroenterology | 1978 | https://conductscience.org/library/papers/340331 | PubMed |
| 5 | 340,329 | Long term cimetidine in the management of severe duodenal ulcer dyspepsia. | Gastroenterology | 1978 | https://conductscience.org/library/papers/340329 | PubMed |
| 6 | 334,336 | Cimetidine in patients with gastric ulcer: a multicentre controlled trial. | Br Med J | 1977 | https://conductscience.org/library/papers/334336 | PubMed |
| 7 | 1,087,420 | A study of the factors influencing mortality rates from gastrointestinal haemorrhage. | Q J Med | 1976 | https://conductscience.org/library/papers/1087420 | PubMed |
| 8 | 57,439 | Treatment of duodenal ulcer with cimetidine. | Lancet | 1976 | https://conductscience.org/library/papers/57439 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 10,601,049 | Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. | Gut | 2000 | https://conductscience.org/library/papers/10601049 | PubMed |
| 7,220,403 | Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers. | Postgrad Med J | 1980 | https://conductscience.org/library/papers/7220403 | PubMed |
| 7,042,486 | Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. | Gut | 1982 | https://conductscience.org/library/papers/7042486 | PubMed |
| 6,387,689 | The effect of cimetidine on the maintenance of healing of gastric ulceration. | Postgrad Med J | 1984 | https://conductscience.org/library/papers/6387689 | PubMed |
| 6,315,333 | Drugs for the prevention of peptic ulcer recurrence. | Drugs | 1983 | https://conductscience.org/library/papers/6315333 | PubMed |
| 6,301,956 | Ranitidine in the prevention of gastric and duodenal ulcer relapse. | Gut | 1983 | https://conductscience.org/library/papers/6301956 | PubMed |
| 6,095,240 | Medical management of peptic ulcer. | Postgrad Med J | 1984 | https://conductscience.org/library/papers/6095240 | PubMed |
| 4,007,604 | Maintenance therapy: a two year comparison between Caved-S and cimetidine treatment in the prevention of symptomatic gastric ulcer recurrence. | Gut | 1985 | https://conductscience.org/library/papers/4007604 | PubMed |
| 3,781,336 | Effects of cimetidine on the healing and recurrence of duodenal ulcers and gastric ulcers. | Gut | 1986 | https://conductscience.org/library/papers/3781336 | PubMed |
| 3,604,233 | The refractory ulcer. | World J Surg | 1987 | https://conductscience.org/library/papers/3604233 | PubMed |
| 3,557,191 | Clinical markers of slow healing and relapsing gastric ulcer. | Gut | 1987 | https://conductscience.org/library/papers/3557191 | PubMed |
| 2,905,242 | Roxatidine acetate in the long term maintenance of gastric ulcers. | Drugs | 1988 | https://conductscience.org/library/papers/2905242 | PubMed |
| 2,196,208 | Sucralfate in the treatment and prevention of gastric ulcer: multicentre double blind placebo controlled study. | Gut | 1990 | https://conductscience.org/library/papers/2196208 | PubMed |
| 1,348,231 | Complications associated with ulcer recurrence following gastric surgery for ulcer disease. | Gastroenterol Jpn | 1992 | https://conductscience.org/library/papers/1348231 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/482183
GET https://conductscience.org/api/papers/v1/482183/authors